Critical evaluation of the off-label indication and of the risks associated to the use of multi-dose vials on the treatment of age-related macular degeneration . Braz. J. Pharm. Sci. [Internet]. 2014 Mar. 1 [cited 2024 May 13];50(1):63-72. Available from: https://revistas.usp.br/bjps/article/view/80851